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Extracellular matrix (ECM) metabolism and homeostasis is sensitive to changes in oxygen tension manifest in
ischemia. We hypothesize that in chronically ischemic limbs, abnormalities in uninjured skin, secondary to
hypoxia, predispose to dermal breakdown. Paired biopsies of uninjured distal ischemic and proximal non-ischemic
skin were harvested at below knee amputation from 14 patients with peripheral vascular disease following
quantiﬁcation of ischemia. Age- and site-matched controls were taken at total knee replacement (TKR) and
varicose vein (VV) operations. Matrix metalloproteinase (MMP)-2 and -9 expression was determined using gelatin
zymography, MMP-1 by western blotting and ELISA and tissue inhibitor of MMP (TIMP) by reverse zymography.
Collagen content was measured by determining hydroxyproline levels, and collagen type I synthesis by ELISA.
Collagen type I synthesis was upregulated in ischemic tissue compared with non-ischemic matched pairs
(po0.001) and both TKR and VV controls, however, there was no increase in collagen deposition. Levels of MMP-2
(po0.0005) and TIMP-2 (po0.01), were elevated in ischemic samples. MMP-9 was unaltered, signifying no
inﬂammatory changes. Tissue ischemia was linked to elevated ECM turnover, associated with matrix failure when
compounded with problems of matrix stabilization, likely in ischemia. This represents a potential mechanism for
ulcer formation.
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Ischemia secondary to peripheral vascular disease (PVD) is
a major cause of dermal ulceration (Cornwall and Dore,
1986) and is responsible for significant morbidity (London
and Donnelly, 2000), with a significant proportion of leg ul-
cers of primarily venous or diabetic etiology also having an
arterial component (Cornwall and Dore, 1986; Ghauri and
Nyamekye, 1998; Liew and Sinha, 1998). In the US up to
one million people suffer from leg ulcers. In addition to their
effect on the quality of life, they represent a significant fi-
nancial drain on health care providers, with lower-extremity
ulcers alone costing the Medicare system $1.5–2 billion a
year (Harrington and Zagari, 2000).
Studies investigating the pathology of such ulceration
have concentrated on processes taking place after ulcers
have formed. But the mechanism of ulcer formation, in par-
ticular the effect of chronic ischemia on macroscopically
normal skin has been largely overlooked.
Collagen is the major component of the extracellular
matrix (ECM) providing most of its mechanical strength and
much of the organization of the scaffold on which cellular
events occur. Type I collagen is the most abundant protein
in skin. It is synthesized as three separate a chains that
assemble within cells such as fibroblasts prior to secretion
as the procollagen molecule. This consists of the mature
collagen with extension peptides at both the amino and
carboxyl termini, which are cleaved prior to incorporation of
the collagen into fibrils. Stabilization of collagen then occurs
by intermolecular cross-linking (Knott and Bailey, 1998). In
vitro studies have shown that in conditions of moderate
hypoxia an upregulation of type I collagen occurs (Stein-
brech and Longaker, 1999). Decreasing the oxygen tension
to 2% transiently increased mRNA expression of pro-a1 (I)
and (III) collagens from cultured human fibroblasts (Yaman-
aka and Ishikawa, 2000) although prolonged exposure to
hypoxia decreased this expression. Self-assembly of the
collagen molecule is a pH-dependent process (Christiansen
and Huang, 2000) in addition, low pO2 directly effects the
function of prolyl and lysyl hydroxylases (De Jong and
Kemp, 1984; Uzawa and Grzesik, 1999) and lysyl oxidase
(Siegel, 1979). These regulate collagen fibrogenesis and
stabilization through cross-link formation. In normal wound
healing, collagen synthesis is upregulated by an increase in
lactate resulting from glycolytic metabolism in response to
local tissue ischemia (Hunt and Conolly, 1978). The changes
occurring to collagen metabolism in vivo in uninjured but
chronically ischemic skin are not known. It is likely that
depressed pO2 and pH associated with hypoxia will pro-
foundly influence events.
In homeostasis, the ECM is in a state of constant re-
modeling, with collagen synthesis balanced by degradation
by proteases such as matrix metalloproteinases (MMP)
Abbreviations: ECM, extracellular matrix; MMP, matrix metal-
loproteinase; PVD, peripheral vascular disease; TIMP, tissue inhib-
itor of MMP; TKR, total knee replacement
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(Woessner, 1991). These are a family of zinc-dependent
endopeptidases with activity against many ECM molecules,
including collagen, and are inhibited by tissue inhibitors of
MMP (TIMP). MMP are the principle mediators of connec-
tive tissue remodeling during homeostatic maintenance and
in response to injury (Birkedal-Hansen, 1995; Tarlton and
Vickery, 1997). Dysregulation of proteolysis would therefore
have widespread effects on processes of ECM mainte-
nance, repair, and organization leading to weakening of tis-
sue as well as altered cell infiltration and migration (Gailit
and Clark, 1994). A distinct expression profile of MMP-2
and -9 and their inhibitors (TIMP-1 and -2) in a normal
wound healing has been demonstrated, (Tarlton and
Vickery, 1997) with an early rise in MMP-9 activity being
linked to an inflammatory cell infiltration and a later rise in
MMP-2 coinciding with reparative events. In chronic venous
ulcers marked upregulation of MMP-2 and -9 was demon-
strated, which was related to ulcer severity, with reduced
levels of TIMP (Tarlton and Bailey, 1999). Levels of MMP-2
have been shown to increase in vitro in cardiac fibroblasts in
response to hypoxia (Bergman and Cheng, 2003), however,
the levels of MMP and TIMP in hypoxic non-injured skin has
not been evaluated.
There is strong evidence that significant tissue hypoxia
contributes to impaired healing (Jonsson and Jensen, 1991;
Hopf and Hunt, 1997), however, the extent to which defi-
ciencies in ECM structure and function, secondary to
chronic hypoxia, predispose to dermal failure and ulcera-
tion is not known.
In this study we hypothesize that ischemia resulting from
peripheral vascular disease will cause a disturbance in
homeostatic collagen turnover in uninjured skin leading to
mechanical weakening and formation of ulcers.
Results
Patients The patient age range was 62–84 y with a mean of
72 y. All patients had documented PVD of at least a year
with an ankle brachial pressure ratio in the affected limb of
less than 0.4 indicating severe ischemia. The mean age of
the total knee replacement (TKR) controls was 71 y with a
range of 57–81 y, and 55 y range 34–68 y for those in the
varicose vein (VV) control group.
Collagen synthesis Collagen synthesis was significantly
increased in the ischemic compared with non-ischemic-
matched paired samples (Fig 1, p¼ 0.0004), and also when
compared with both the proximal (TKR, po0.01 and distal;
VV, po0.005 control tissues; Fig 2) No difference was dem-
onstrated between controls and non-ischemic samples
(Fig 2, p40.5).
Collagen content Despite the increase in collagen syn-
thesis the levels of total collagen were unaltered in the
ischemic compared with non-ischemic samples (Fig 3,
p40.5). These levels were comparable with those in both
the VV and TKR control tissues.
MMP-2, -9 and TIMP Figure 4 shows typical zymograms (a)
and reverse zymograms (b) for quantization of gelatinases
and TIMP, respectively. Levels of pro-MMP-2 were signif-
icantly elevated in the ischemic samples compared with
both the non-ischemic samples (Fig 5, po0.001) and con-
trol samples (Fig 6, po0.02). No significant difference was
demonstrated between control and non-ischemic samples
(Fig 6, p40.5). Levels of activated MMP-2 were also in-
creased in the ischemic samples compared with non-is-
chemic (Fig 7, po0.0005) and control (Fig 8, po0.02)
specimens. Again, no significant differences was seen be-
tween non-ischemic and control samples (Fig 8, p40.2).
But there was no increase in the proportion of MMP-2 found
in the activated state (p40.5, data not shown). MMP-9 was
unchanged in the ischemic samples when compared with
non-ischemic tissue and controls.
Levels of TIMP-2 were elevated in ischemic samples
compared with both non-ischemic tissue (Fig 9, po0.005).
MMP-9 was unchanged in the ischemic samples when
Figure1
Collagen synthesis in the ischemic samples expressed as a per-
centage of the matched non-ischemic values. Ischemic skin had
significantly higher collagen synthesis than the paired non-ischemic
tissue (p¼ 0.0004 Wilcoxon’s signed-rank test).
Figure2
Collagen synthesis expressed as type I collagen C propeptide
(PICP) levels (ng per mg) of ischemic, non-ischemic, and controls
(varicose vein (VV) and total knee replacement (TKR)). Comparing
ischemic with non-ischemic (p¼ 0.0004 Wilcoxon’s signed-rank test),
ischemic and VV (po0.005), and ischemic with TKR (po0.01) (unpaired
t test with Welch correction). Error bars showing standard error of
mean. No statistical difference was found between VV, TKR, and non-
ischemic samples (p40.5 unpaired t test with Welch correction).
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compared with non-ischemic tissue and controls. No sig-
nificant change was seen in TIMP-1.
Western blotting was able to detect pro-MMP-1 at levels
of 10 pg. Pro-MMP-1 was shown to be significantly up-
regulated in ischemic compared with non-ischemic skin
(Fig 10, po0.01), using western blotting. ELISA was not able
to detect pro-MMP-1 in most samples, but those samples
with detectable levels corroborated the western blotting
results (data not shown).
Discussion
The pathophysiology of ulcer formation in venous and ar-
terial disease is not clearly understood. Clyne and Ramsden
(1985) demonstrated a reduced transcutaneous oxygen
tension in the gaiter areas of patients with venous ulceration
and Falanga and McKenzie (1991) revealed heterogeneous
oxygen levels around venous ulcers. Borzykowski and
Krahenbuhl (1981) found that local hypoxia constitutes an
important feature of many kinds of ulcers even when venous
disease is the primary cause. In PVD ulcers occur in the
most distal and hypoxic regions with ulcer healing rarely
occurring without revascularization. That hypoxia is asso-
ciated with tissue ulceration has been established, however,
a mechanism by which such hypoxia leads to tissue break-
down and the effect of chronic ischemia on ECM metab-
olism in macroscopically normal skin is not known.
The study of ischemic human tissue has previously been
limited by ethical considerations to small biopsies from in-
cision margins at operation, or wound fluid exudates. Age-
matched control tissue for such studies inevitably have
been difficult to obtain. By studying tissue taken from is-
chemic and non-ischemic sites harvested at amputation we
have studied not only age but also patient-matched skin
allowing for accurate evaluation of ECM changes. By also
Figure 3
Total collagen content of sample as determined from hydroxypro-
line analysis. No difference was detected in the collagen content
between ischemic and non-ischemic skin (a) in individual ischemic
samples expressed as a percentage of the matched non-ischemic
values, and (b) grouped non-ischemic compared with ischemic
samples, expressed as % collagen. Error bars expressing standard
error of mean (p40.5 Wilcoxon’s signed-rank test).
Figure 4
Example of (a), matrix metalloproteinase (MMP) zymogram and (b), tissue inhibitor of MMP (TIMP) reverse zymogram. Non-ischemic
followed by ischaemic samples displayed in matched pairs.
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studying site-matched control tissue we have established
that the changes seen in the matrix metabolism secondary
to ischemia are not because of site-specific characteristics.
Using this novel approach we have shown that that in
chronically hypoxic tissues a marked increased turnover of
collagen occurs within the ECM. We have also shown that
the upregulation in collagen synthesis demonstrated in vitro
(Falanga and Zhou, 2002) in response to hypoxia also oc-
curs in non-injured chronically ischemic skin. But despite
this increase in collagen synthesis, the total collagen con-
tent of samples was unaltered, indicating a probable in-
creased collagen degradation in the tissues. There was no
change in the hydroxylation of the collagen, as measured by
lysine:hydroxylysine ratios (data not shown), therefore it is
unlikely that the collagen content data results from an ar-
tifact of altered collagen hydroxylation. These findings con-
trast with those seen in venous disease where an increased
lysine:hydroxylisine is found in lipodermatosclerotic skin at
risk of ulceration (Brinckmann and Acil, 1996). Increased
levels of the both pro and active forms of MMP-2, -1, and
TIMP-2 indicate increased ECM turnover in response to
chronic ischemia. Increased proteolytic activity has been
documented in vitro and in wound fluid in response to
hypoxia but not within uninjured skin samples. Elevated
levels of active MMP-2 has been demonstrated in skin bi-
opsies of patients with chronic venous insufficiency where
significant dermal changes occur (Saito and Trovato, 2001).
The mechanism for this elevation is not known, however, the
source is likely to be dermal fibroblasts and migrating le-
ukocytes (Saito and Trovato, 2001). In the ischemic skin
levels of MMP-9 were not significantly elevated suggesting
that significant leukocytes migration was not occurring nor
Figure 5
Pro-matrix metalloproteinase (MMP)-2 levels in the ischemic
samples expressed as a percentage of the matched non-ischemic
values. There was greater expression of pro-MMP-2 in ischemic
samples compared with non-ischemic samples (po0.001 Wilcoxon’s
signed-rank test).
Figure 6
Pro-matrix metalloproteinase (MMP)-2 levels of ischemic, non-is-
chemic, and controls (varicose vein (VV) and total knee replace-
ment (TKR)) expressed as% of MMP-2 standard. Error bars showing
standard error of mean. No statistical difference was found between VV,
TKR, and non-ischemic samples (p40.5, unpaired t test with Welch
correction). Comparing; ischemic with non-ischemic, po0.001 (Wilco-
xon’s signed-rank test), ischemic and VV, po0.02, and ischemic with
TKR po0.02 (unpaired t test with Welch correction).
Figure7
Active matrix metalloproteinase (MMP)-2 levels in the ischemic
samples expressed as a percentage of the matched non-ischemic
values. Higher levels of active MMP-2 were detected in the ischemic
compared with non-ischemic samples (po0.001 Wilcoxon’s signed-
rank test).
Figure8
Pro-matrix metalloproteinase (MMP)-2 levels of ischemic, non-is-
chemic, and controls (varicose vein (VV) and total knee replace-
ment (TKR)) expressed as % of MMP-2 standard. Error bars showing
standard error of mean. No statistical difference was found between VV,
TKR, and non-ischemic samples (p40.5 unpaired t test with Welch
correction). Comparing; ischemic with non-ischemic, po0.001 (Wilco-
xon’s signed-rank test), ischemic and VV, po0.005, and ischemic with
TKR po0.05 (unpaired t test with Welch correction).
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were they demonstrating early wound healing events (Tarl-
ton and Vickery, 1997).
It is also unlikely that reactive oxygen species are in-
volved in this mechanism, as there is no induction of MMP-
9, nor an increase in the proportion of MMP-2 found in the
activated state, both would be expected in the presence of
oxygen free radicals (Gurjar, 2001; Zhang, 2002). In unin-
jured, non-ischemic skin, the ECM is maintained in a dy-
namic state of remodeling, our findings suggest that in
chronic ischemia there is an abnormally increased ECM
turnover. In conditions of disturbed collagen synthesis for
example, Scurvy (Cohen and Keiser, 1976) it is those tissues
with the greatest collagen turnover such as the periodontal
ligament or existing scar tissue that are predisposed to early
failure. We postulate that in chronic ischemia a combination
of increased matrix remodeling and impaired collagen stab-
ilization in hypoxia leads to a greater risk of dermal break-
down and ulcer formation. Increased ECM metabolism may
alter the mechanical stability of collagen within areas of
chronic ischemia leading to its weakening and breakdown,
as well as increasing susceptibility to other disturbances in
matrix metabolism resulting from ischemia. This represents
a previously unidentified mechanism for ulcer formation.
Materials and Methods
Unless otherwise stated, chemicals and other reagents were ob-
tained from Sigma (Poole, UK). All procedures involving human
subjects comply with the World Medical Association declaration of
Helsinki on ethical principles for medical research.
Sample collection and preparation Following ethical approval
and informed consent 8 mm skin biopsies were taken at the time of
operation from the lower limbs of 14 patients undergoing below
knee amputation for PVD. A patient history proforma was com-
pleted for each patient documenting co-pathology and medication.
Patients requiring immuno-suppressant medication in the last 5 y
or with a history of diabetes or renal failure were excluded from the
study. All patients were assessed clinically by one of two consult-
ant vascular surgeons, and had a history of peripheral ischemia
secondary to PVD in the affected limb for at least a year, neces-
sitating amputation. The level of ischemia was assessed preoper-
atively using the ‘‘ankle brachial pressure index’’ (Rosenbloom and
Flanigan, 1988; Ameli and Stein, 1989). In all cases the ratio was
o0.4 signifying severe ischemia (Rutherford and Baker, 1997). Bi-
opsies were harvested after anesthesia and skin preparation but
prior to amputation from two predetermined sites. Biopsy one was
taken from the non-ischemic proximal resection margin on the
medial aspect of the leg 4 cm inferior to the tibial tuberosity and
biopsy two from the ischemic distal region 2 cm above the medial
malleolus. Control tissue was taken from skin at TKR and VV sur-
gery giving proximal and distal site-matched controls. The ABPI
was measured in all control patients and was X1.0 signifying no
clinically detectable limb ischemia. All samples were immediately
frozen in liquid nitrogen. Tissue was pulverized, freeze dried and
extracted for 24 h in 20 mL of extract buffer (20 mM triethanolamine
and 0.1% Brij) per mg dry weight. The extract mixture was cen-
trifuged, the supernatant separated from the insoluble matrix pel-
let. A fat extraction was performed on the pellet using 2:1
chloroform and methanol, in order to establish the true dry mass
of the skin, which was used in all compositional calculations.
Samples were stored at 801C until required.
Collagen synthesis Type I collagen C propeptides (PICP) quan-
titation is the standard procedure for determining type I collagen
synthesis rates (Tarlton and Bailey, 1999). This was performed us-
ing a sandwich ELISA (Prolagen C, Quidel, Oxon, UK). Tissue ex-
tracts were diluted 1:12 in the assay buffer provided. A dilution
series of 0, 2, 5, 20, and 80 ng per mL PICP generated a standard
curve fitted with a polynomial curve fit, the formula for which was
Figure 9
Tissue inhibitor of MMP (TIMP) levels in ischemic and non-
ischemic skin. There was greater expression of TIMP-2 in ischemic
compared with non-ishemic skin (a) in individual ischemic samples
expressed as a percentage of the matched non-ischemic values
(po0.001 Wilcoxon’s signed-rank test), and (b) grouped non-ischemic
compared with ischemic skin expressed as % of TIMP-2 standard.
Error bars showing standard error of mean (po0.001 Wilcoxon’s
signed-rank test).
Figure10
Pro-matrix metalloproteinase (MMP)-1 levels in ischemic and non-
ischemic skin. There was greater expression of Pro-MMP-1 in
ischemic compared with non-ischemic skin, as determined by western
blotting (po0.01, Wilcoxon’s signed-rank test).
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used to calculate the concentration of test samples from their ab-
sorbance readings at 405 nm.
Collagen content Skin collagen contents were measured by cal-
culating the level of the collagen-specific amino-acid hydroxy-
proline within the insoluble matrix pellet (Knott and Bailey, 1997).
Hydroxyproline constitutes 14% of type I collagen and was meas-
ured colorimetrically. Less than 1% of the total collagen was found
in the extract (data not shown), and was therefore discounted. The
insoluble matrix pellets following extraction were borohydride re-
duced, hydrolyzed for 18 h in 6 M HCl and freeze dried prior to
diluting to bring the concentration of the hydroxyproline in the hy-
drolysates within the range of the analyzer (0–5 mg per mL). Sam-
ples were oxidized with chloramine-T and the resulting pyrole
coupled to 4-dimethlaminobenzaldehyde. The colored product
was then analyzed on a continuous flow autoanalyzer (Chemlab,
Essex, UK) at an absorbency of 550 nm. Standards were prepared
from a solution of L-hydroxyproline in 0.01 M HCl.
Analysis of MMP-2 and -9 Gelatin substrate gel electrophoresis
was performed as previously described (Tarlton and Vickery, 1997).
In brief, tissue extracts were mixed 1:4 with non-reducing sample
buffer to give a final dilution of 80 mL of per mg dry weight and
10 mL loaded onto 10% SDS-PAGE gels containing 0.75 mg per mL
bovine gelatin in a protean II gel apparatus (Bio-Rad, Hemel
Hempstead, UK). After electrophoresis, gels were washed in 2.5%
Triton X-100, and incubated for 16 h at 371C in MMP proteolysis
buffer (50 mM tris/HCl, pH 7.8, 50 mM CaCl2, 0.5 M NaCl, and
0.1 mM aminophenyl mercuric acetate). Gels were stained with 0.2%
Coomassie blue (R250, Bio-Rad) and destained until the zones of
proteolysis or the stacking gel had cleared. Loading standards of
MMP-2 and -9 (Biogenesis, Bournmouth, UK) corroborated the
identification of pro- and activated gelatinases. Gelatinase activity
was related to that of the standard MMP-2 to enable quantification
and comparison between separate gels. Throughout the study
patient-matched samples were always examined in parallel. Densi-
tometry was used to quantify the zones of proteolysis as previously
described (Tarlton and Knight, 1996). In brief an Agfa Studioscan
color flatbed scanner was used in transmittance mode, utilizing
Fotolook scanning software with a correction curve applied to
maintain linearity of the scanner response. The image was analy-
zed in NIH Image 1.5, and the proteolytically clarified zones were
quantitated according to both area and intensity.
TIMP The methodology was as above except that 0.5 mg recom-
binant tissue MMP-2 (Calbiochemic, Nottingham, UK) was added
to a 12% resolving gel and standards of TIMP-2 (Amersham,
Chalford St. Guiles, UK) were loaded alongside that of the diluted
tissue extract. Gels were incubated for 48 h and TIMP levels within
the tissue extract were revealed as darker regions where the co-
polymerized MMP-2 degradation of the gelatin substrate was in-
hibited. Densitometry was used for quantification as described
(Tarlton and Knight, 1996).
MMP-1 western blotting and ELISA Tissues were pulverized in a
freezer mill, wet weight determined, and lysis buffer (20 mM HE-
PES, pH 7.5, protease inhibitors leupeptin, AEBSF, E64, SBTI,
pepstatin, aprotonin) added at the ratio of 200 mL buffer to 100 mg
tissue wet weight. Tissue were extracted for 2 h shaking then
overnight static at 41C. Samples centrifuged 41C, 10 min, 8000 g.
Supernatant stored at 201C, pellets were then fat extracted in 3:1
chloroform:methanol, then freeze dried and the fat-free dry weight
determined.
An equal volume of lysates (eight ischemic/non-ischemic pairs,
and one sample of arterial ulcer) was added to lanes at the equiv-
alent of 0.128 mg dry weight per lane and proteins separated using
8% PAGE gels. Proteins were transferred to PVDF membrane
(Millipore, Billerica, Massachusetts), blocked with 5% non-fat milk
powder and the incubated overnight in blocking buffer containing
goat anti-MMP-1 antibody (1:500, Santa Cruz, Biotechnology, Inc.,
Santa Cruz, California). After washing, blots were incubated with
peroxidase-conjugated donkey anti-goat secondary antibody
(1:20,000; Stratech, Cambridge, UK) for 1 h at 201C. Blots were
developed by ECL (Luminol, Santa Cruz), and densitometry was
used to quantify bands as described (Tarlton and Knight, 1996).
Pro-MMP-1 levels were also analyzed using R&D kit (R&D
Systems, Minneapolis, Minnesota) as per manufacturers instruc-
tions. An equal volume of lysate was added to wells at the equiv-
alent of 1.15 mg dry weight tissue per well for all samples (10
ischemic/non-ischemic pairs, and one sample of arterial ulcer).
Statistical analyses All data are expressed as the mean  SEM.
Two-tailed Wilcoxon’s-matched pairs signed-rank tests were per-
formed on the paired data with unpaired t tests on the controls
using Instat software. Probabilities, where appropriate, given as p-
values with po0.05 are regarded as significant. Normality of the
data was assessed using Instat software and corrected where
necessary with a Welch correction.
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